Hylemon, Phillip B.

Bile salt biotransformations by human intestinal bacteria

Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research

Gut microbiota and healthSteroid Chemistry and Biochemistry

Cited by 2,829

Bile acids and the gut microbiome

Ridlon, J. M., Kang, D. J., Hylemon, P. B., & Bajaj, J. S. (2014) · Current Opinion in Gastroenterology

Gut microbiota and healthDrug Transport and Resistance Mechanisms

Cited by 1,329

Altered profile of human gut microbiome is associated with cirrhosis and its complications

Bajaj, J. S., Heuman, D. M., Hylemon, P. B., Sanyal, A. J., White, M. B., Monteith, P., Noble, N. A., Unser, A. B., Daita, K., Fisher, A. R., et al. (2014) · Journal of Hepatology

Gut microbiota and healthLiver Disease and Transplantation

Cited by 1,099

Bile acids as regulatory molecules

Hylemon, P. B., Zhou, H., Pandak, W. M., Ren, S., Gil, G., & Dent, P. (2009) · Journal of Lipid Research

Drug Transport and Resistance MechanismsCholesterol and Lipid Metabolism

Cited by 694

Linkage of gut microbiome with cognition in hepatic encephalopathy

Bajaj, J. S., Ridlon, J. M., Hylemon, P. B., Thacker, L. R., Heuman, D. M., Smith, S., Sikaroodi, M., & Gillevet, P. M. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology

Gut microbiota and healthLiver Disease and Transplantation

Cited by 547

Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy

Bajaj, J. S., Heuman, D. M., Sanyal, A. J., Hylemon, P. B., Sterling, R. K., Stravitz, R. T., Fuchs, M., Ridlon, J. M., Daita, K., Monteith, P., et al. (2013) · PLoS ONE

Liver Disease and TransplantationGut microbiota and health

Cited by 430

The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids

Puri, P., Daita, K., Joyce, A., Mirshahi, F., Santhekadur, P. K., Cazanave, S., Luketic, V. A., Siddiqui, M. S., Boyett, S., Min, H., et al. (2018) · Hepatology

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 426

Cirrhosis, bile acids and gut microbiota: Unraveling a complex relationship

Ridlon, J. M., Alves, J. M., Hylemon, P. B., & Bajaj, J. S. (2013) · Gut Microbes

Gut microbiota and healthLiver Disease and Transplantation

Cited by 336

Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy

Bajaj, J. S., Betrapally, N. S., Hylemon, P. B., Heuman, D. M., Daita, K., White, M. B., Unser, A., Thacker, L. R., Sanyal, A. J., Kang, D. J., et al. (2015) · Hepatology

Gut microbiota and healthLiver Disease and Transplantation

Cited by 325

Clostridium scindens: a human gut microbe with a high potential to convert glucocorticoids into androgens

Ridlon, J. M., Ikegawa, S., Alves, J. M. P., Zhou, B., Kobayashi, A., Iida, T., Mitamura, K., Tanabe, G., Serrano, M., De Guzman, A., et al. (2013) · Journal of Lipid Research

Steroid Chemistry and BiochemistryGut microbiota and health

Cited by 319

Bile acids are nutrient signaling hormones

Zhou, H., & Hylemon, P. B. (2014) · Steroids

Drug Transport and Resistance MechanismsCholesterol and Lipid Metabolism

Cited by 285

Identification and Characterization of a Bile Acid 7α-Dehydroxylation Operon in Clostridium sp. Strain TO-931, a Highly Active 7α-Dehydroxylating Strain Isolated from Human Feces

Wells, J. E., & Hylemon, P. B. (2000) · Applied and Environmental Microbiology

Steroid Chemistry and BiochemistryGut microbiota and health

Cited by 154

Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function

Bajaj, J. S., Cox, I. J., Betrapally, N. S., Heuman, D. M., Schubert, M. L., Ratneswaran, M., Hylemon, P. B., White, M. B., Daita, K., Noble, N. A., et al. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology

Gut microbiota and healthLiver Disease and Transplantation

Cited by 143

Diet affects gut microbiota and modulates hospitalization risk differentially in an international cirrhosis cohort

Bajaj, J. S., Idilman, R., Mabudian, L., Hood, M., Fagan, A., Turan, D., White, M. B., Karakaya, F., Wang, J., Atalay, R., et al. (2018) · Hepatology

Gut microbiota and healthLiver Disease and Transplantation

Cited by 125

Gut microbiota, cirrhosis, and alcohol regulate bile acid metabolism in the gut

Ridlon, J. M., Kang, D.-J., Hylemon, P. B., & Bajaj, J. S. (2015) · Digestive Diseases

Gut microbiota and healthDrug Transport and Resistance Mechanisms

Cited by 109

Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease

Xue, R., Su, L., Lai, S., Wang, Y., Zhao, D., Fan, J., Chen, W., Hylemon, P. B., & Zhou, H. (2021) · Cells

Liver Disease Diagnosis and TreatmentDrug Transport and Resistance Mechanisms

Cited by 95

Cloning, sequencing, and expression of the gene coding for bile acid 7 alpha-hydroxysteroid dehydrogenase from Eubacterium sp. strain VPI 12708

Baron, S. F., Franklund, C. V., & Hylemon, P. B. (1991) · Journal of Bacteriology

Steroid Chemistry and BiochemistryMicrobial bioremediation and biosurfactants

Cited by 80

HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients

Bajaj, J. S., Sterling, R. K., Betrapally, N. S., Nixon, D. E., Fuchs, M., Daita, K., Heuman, D. M., Sikaroodi, M., Hylemon, P. B., White, M. B., et al. (2016) · Alimentary Pharmacology & Therapeutics

Gut microbiota and healthHepatitis C virus research

Cited by 63